Medical/Pharmaceuticals
Flat Medical Expands Leadership Team to Manage Growth in Europe and the United States
TAIPEI, June 28, 2023 /PRNewswire/ -- Flat Medical Co. Ltd., a leading MedTech company specializing in safety solutions for anesthesia and critical care, is pleased to announce the appointment of two executives who will spearhead the company's expansion inEurope and America. Jan Wormmeester has b...
2023-06-28 20:30
1834
Sanyou Forms Partnership with Hangzhou Zhongmei Huadong Pharmaceutical, Catalyzing Innovative Drug Research and Development
SHANGHAI, June 28, 2023 /PRNewswire/ -- Recently, Sanyou Biopharmaceuticals Co., Ltd. (hereinafter referred to as Sanyou) and Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd, a wholly-owned subsidiary of Huadong Medicine Co., Ltd. (SZ.000963) (hereinafter referred to asHuadong Medicine), signed...
2023-06-28 20:00
1937
Babies Bliss Introduces Comprehensive Fertility Wellness Programme to Enhance Reproductive Health and Conception Journey
SINGAPORE, June 28, 2023 /PRNewswire/ -- Babies Bliss, a Singapore-based fertility wellness centre, is proud to announce its innovative fertility wellness programme designed to support women in improving their reproductive health and preparing their bodies for conception. The comprehensive progra...
2023-06-28 18:44
2184
Caliway Announces Positive Data from CBL-0201EFP Phase 2-Stage 1 Study of CBL-514 in Treating Moderate to Severe Cellulite
* CBL-514 is the only non-invasive product that can improve 1-level of cellulite severity two weeks after a single treatment. * The highest dose of CBL-514 treatment demonstrated the best efficacy, 87.5% of thighs achieved at least 1-level improvement in cellulite severity two weeks after CBL...
2023-06-28 18:30
1881
European Society of Hypertension Announces Comprehensive New Guidelines for the Management of Arterial Hypertension
MILAN, June 28, 2023 /PRNewswire/ -- The European Society of Hypertension (ESH), the leading hypertension society inEurope, released updated and expanded 2023 ESH Guidelines for the Management of Arterial Hypertension during three oral presentations atthe 32nd Annual European Meeting on Hypertens...
2023-06-28 18:00
7336
Lo.Li. Pharma International and its International Partners Achieve a New World Record to Raise Awareness About Innovative Options for Managing PCOS and Infertility
COPENHAGEN, Denmark, June 28, 2023 /PRNewswire/ -- The Society of Human Reproduction and Embryology (ESHRE) annual meeting witnessed a historic event as people from around the globe gathered both in person and online to set a new world record for the most people consuming a dose of inositol simul...
2023-06-28 17:25
2488
Nuance Pharma's Partner Verona Pharma Submits New Drug Application to US FDA for Ensifentrine for the Maintenance Treatment of COPD
SHANGHAI, June 28, 2023 /PRNewswire/ -- Nuance Pharma announces its partner, Verona Pharma plc (Nasdaq: VRNA), has submitted a New Drug Application ("NDA") to the US Food and Drug Administration ("FDA") for approval of ensifentrine for the maintenance treatment of patients with chronic obstructi...
2023-06-28 17:07
3382
Xuanzhu Biopharm, a subsidiary of Sihuan Pharmaceutical, Its Innovative Drug Anaprozole Sodium Enteric-coated Tablets Obtains Drug Registration Approval From NMPA
HONG KONG, June 27, 2023 /PRNewswire/ -- Sihuan Pharmaceutical Holdings Group Ltdtogether with its subsidiaries, is pleased to announce that Xuanzhu Biopharmaceutical Co., Ltd. ("Xuanzhu Biopharm"), a non-wholly owned subsidiary of Company, has received a drug registration approval from the Natio...
2023-06-28 09:57
1933
LYMPHOMA THERAPY NOW APPROVED FOR AUSTRALIAN PATIENTS With Diffuse Large B-cell Lymphoma
MINJUVI® (tafasitamab) provisionally approved by Therapeutic Goods Administration[1] Recent five-year follow-up data from Phase 2 L-MIND investigation showed patients treated with MINJUVI had prolonged, durable responses[2] SINGAPORE, June 27, 2023 /PRNewswire/ -- Independent biopharmaceutical ...
2023-06-28 04:00
1899
First Drug Discovered and Designed with Generative AI Enters Phase II Trials, with First Patients Dosed
* After completing the Phase 0 and Phase I human safety studies, INS018_055, Insilico's AI-discovered and AI-generated drug, has entered multi-regional Phase II clinical trials in the U.S andChina. * The first human patients were dosed with the drug. * This is a potentially first-in-class an...
2023-06-27 21:00
3101
TMRW Life Sciences Names Louis Villalba Chief Executive Officer
Seasoned Executive Appointed to Lead Fast-Growing Technology Company as It Signs 50 Fertility Clinics Representing Nearly 20% Market Share NEW YORK, June 27, 2023 /PRNewswire/ -- Today, TMRW Life Sciences, Inc. ("TMRW"), a fertility technology company automating the IVF lab, appointedLouis Villa...
2023-06-27 20:00
1814
EXCELLENT CLINICAL DATA FOR SUBB2M/CA15-3 BREAST CANCER TEST
* INOVIQ's SubB2M/CA15-3 breast cancer test detects all-stages of breast cancer with excellent accuracy (87%), sensitivity (81%) and specificity (93%) * The results of a comprehensive 483-sample case-control study established that INOVIQ's SubB2M/CA15-3 blood test significantly outperformed a ...
2023-06-27 19:00
2072
Innovative paper-like, battery-free, AI-enabled sensor for holistic wound monitoring
SINGAPORE, June 27, 2023 /PRNewswire/ -- Timely and effective monitoring of wound healing status is critical to wound care and management. Impaired wound healing, such as chronic wounds (i.e. those that do not heal after 3 months) and post-burn pathological scars, could result in life-threatening...
2023-06-27 16:53
2153
Pharmadule Morimatsu and WuXi Biologics Reached Global Strategic Partnership
SHANGHAI, June 27, 2023 /PRNewswire/ -- June 26th, 2023, Pharmadule Morimatsu
and WuXi Biologics officially entered into a global strategic cooperation for
the Singapore CRDMO Center project of WuXi Biologics.
2023-06-27 15:33
2847
Lion TCR Secures USD 40 million Series B2 Financing, Revolutionizing Solid Tumor Treatment with mRNA-Encoding TCR-T Cell Therapy
SINGAPORE and GUANGZHOU, China, June 27, 2023 /PRNewswire/ -- 27 June 2023, Lion TCR, a clinical-stage T-cell immunotherapy company, is thrilled to announce the successful completion of itsUSD 40 million Series B2 financing round. Guangzhou Industrial Investment and Capital Operation Holding Grou...
2023-06-27 08:30
3099
CStone announces GAVRETO® (pralsetinib) sNDA approval by China NMPA for first-line treatment of patients with locally advanced or metastatic RET fusion-positive non-small cell lung cancer
* The approval for the first-line treatment of RET fusion-positive non-small cell lung cancer marks the third indication of GAVRETO in Mainland China, and the eleventh new drug application approval that CStone has obtained inGreater China overall. * In the ARROW study, GAVRETO had demonstrate...
2023-06-27 08:05
3048
New ZIRCON Phase III Data Presented at SNMMI: Potential Utility of TLX250-CDx in Staging and Monitoring ccRCC
MELBOURNE, Australia, June 27, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces further details of the positive results from its completed pivotal Phase III ZIRCON study of TLX250-CDx (89Zr-DFO-girentuximab) in clear cell renal cell carcinoma (ccRC...
2023-06-27 03:51
2162
DentalMonitoring reinvents the scan experience
PARIS and AUSTIN, Texas, June 26, 2023 /PRNewswire/ -- DentalMonitoring announces their latest innovation, ScanAssist, the only AI-guided scan process available in orthodontics, designed to provide a fun, engaging patient experience, while also providing unprecedented photo quality for clinical ...
2023-06-26 23:43
2442
Baird Medical, A Leading Developer and Provider of Microwave Ablation (MWA) Medical Devices in China, to be Publicly Listed on NASDAQ through a Proposed Business Combination with ExcelFin Acquisition Corp.
* Ranked first among MWA medical device providers in thyroid nodule and breast lump treatment with approximately 35% market share inChina[1] * Extensive distribution network with over 430 hospitals penetrated and national coverage across 21 provinces, municipalities, and autonomous regions in ...
2023-06-26 21:54
4052
HitGen launches a newly upgraded version of OpenDEL™, a self-service screening kit, to facilitate innovative drug discovery research
CHENGDU, China, June 26, 2023 /PRNewswire/ -- HitGen Inc. ("HitGen", SSE: 688222.SH) has recently launched a newly upgraded version of its OpenDEL™ product, a self-service screening kit for novel molecules. It contains 65% more DEL libraries than the previous version, and with over 3 billion comp...
2023-06-26 21:30
2483
Week's Top Stories
Most Reposted
Agoda releases generative AI film to capture the joy of travel
[Picked up by 349 media titles]
2024-12-10 10:00
Mastercard Economics Institute: APAC growth expected to hold steady in 2025; global policy resets may see shift in gears
[Picked up by 313 media titles]
2024-12-10 09:00Building Asia's Future: Omni HR Secures $7.4mn for HR Tech Expansion
[Picked up by 306 media titles]
2024-12-09 10:00
CCTV+: Yuhang Journey ǀ Follow Olivier to Explore Ancient Liangzhu and Savor Jingshan Tea
[Picked up by 283 media titles]
2024-12-08 20:076th HIIFF Closes with Golden Coconut Award Ceremony
[Picked up by 282 media titles]
2024-12-11 22:19
Most Read
Agoda releases generative AI film to capture the joy of travel
2024-12-10 10:00
3679
Blokees' Figures from Multiple IPs Amaze Fans at 2024 Singapore Comic Con
2024-12-08 00:23
3545
Building Asia's Future: Omni HR Secures $7.4mn for HR Tech Expansion
2024-12-09 10:00
3469